Treatment and Prevention of Heparin-Induced Thrombocytopenia Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

@inproceedings{Linkins2011TreatmentAP,
  title={Treatment and Prevention of Heparin-Induced Thrombocytopenia Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines},
  author={L A Linkins and Antonio Miguel Limcaco Dans and Col Lisa K Moores and Robert D Bona and Bruce L Davidson and Sam Schulman and Mark Andrew Crowther},
  year={2011}
}
2.1.1. For patients receiving heparin in whom clinicians consider the risk of HIT to be . 1%, we suggest that platelet count monitoring be performed every 2 or 3 days from day 4 to day 14 Background: Heparin-induced thrombocytopenia (HIT) is an antibody-mediated adverse drug reaction that can lead to devastating thromboembolic complications, including pulmonary embolism, ischemic limb necrosis necessitating limb amputation, acute myocardial infarction, and stroke. Methods: The methods of this… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 139 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 164 references

Similar Papers

Loading similar papers…